Stock listing
NASDAQ:KROS Keros Therapeutics, Inc. Stock
Home listing (NASDAQ) of Keros Therapeutics, Inc.
Follow Keros Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:KROS
$10.76 USD -0.28 (-2.5%)
Close on Nov 2, 2026
- Day range
- $10.53 – $11.39 USDNov 2, 2026
- Volume
- 139,244 sharesNov 2, 2026
- Market cap
- $213.3M USDAt the close on Nov 2, 2026 · price × 19.83M shares outstanding
- 52-week range
- $9.69 – $22.55 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $2.08M USDMedian day 178,100 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:KROS · Home | $10.76 USD | -0.28 (-2.5%) | 139,244 | $11.12 | $11.39 | $10.53 | $11.04 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:KROS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $10.76 | -0.28 | -2.5% | $11.12 | $11.39 | $10.53 | 139,244 | |
| $11.04 | -0.32 | -2.8% | $11.36 | $11.49 | $10.98 | 120,157 | |
| $11.36 | -0.25 | -2.2% | $11.71 | $11.87 | $11.21 | 205,017 | |
| $11.61 | +0.185 | +1.6% | $11.34 | $11.79 | $11.20 | 183,223 | |
| $11.43 | +0.095 | +0.8% | $11.37 | $11.60 | $11.19 | 148,511 | |
| $11.33 | +0.05 | +0.4% | $11.30 | $11.51 | $11.20 | 112,409 | |
| $11.28 | -0.07 | -0.6% | $11.28 | $11.34 | $10.92 | 120,900 | |
| $11.35 | +0.17 | +1.5% | $11.15 | $11.44 | $11.15 | 115,500 | |
| $11.18 | -0.22 | -1.9% | $11.40 | $11.68 | $11.11 | 178,100 | |
| $11.40 | +0.34 | +3.1% | $11.04 | $11.67 | $11.04 | 153,400 | |
| $11.06 | +0.40 | +3.8% | $10.68 | $11.15 | $10.66 | 210,600 | |
| $10.66 | -0.44 | -4.0% | $11.11 | $11.13 | $10.63 | 169,600 | |
| $11.10 | +0.05 | +0.5% | $11.13 | $11.40 | $10.98 | 96,700 | |
| $11.05 | -0.18 | -1.6% | $11.07 | $11.30 | $10.92 | 159,100 | |
| $11.23 | -0.38 | -3.3% | $11.65 | $11.69 | $11.19 | 144,300 | |
| $11.61 | -0.34 | -2.8% | $11.77 | $12.08 | $11.58 | 223,700 | |
| $11.95 | +0.31 | +2.7% | $11.58 | $12.26 | $11.49 | 194,400 | |
| $11.64 | +0.43 | +3.8% | $11.13 | $11.76 | $10.99 | 245,700 | |
| $11.21 | +0.20 | +1.8% | $10.81 | $11.34 | $10.81 | 196,000 | |
| $11.01 | -0.51 | -4.4% | $11.56 | $11.63 | $10.95 | 185,300 | |
| $11.52 | +0.16 | +1.4% | $11.38 | $11.56 | $11.07 | 132,400 | |
| $11.36 | +0.10 | +0.9% | $11.38 | $11.44 | $11.01 | 231,500 | |
| $11.26 | -0.14 | -1.2% | $11.38 | $11.44 | $11.08 | 140,200 | |
| $11.40 | +0.21 | +1.9% | $11.25 | $11.58 | $11.16 | 131,200 | |
| $11.19 | -0.09 | -0.8% | $11.24 | $11.46 | $11.15 | 118,300 | |
| $11.28 | -0.34 | -2.9% | $11.33 | $11.41 | $10.93 | 208,600 | |
| $11.62 | +0.07 | +0.6% | $11.54 | $11.70 | $11.29 | 216,100 | |
| $11.55 | -0.08 | -0.7% | $11.60 | $11.60 | $10.97 | 284,400 | |
| $11.63 | -0.10 | -0.9% | $11.68 | $11.82 | $11.47 | 157,500 | |
| $11.73 | +0.25 | +2.2% | $11.54 | $12.05 | $11.43 | 189,800 | |
| $11.48 | +0.29 | +2.6% | $11.31 | $11.60 | $11.08 | 120,700 | |
| $11.19 | -0.17 | -1.5% | $11.32 | $11.40 | $11.10 | 302,500 | |
| $11.36 | +0.62 | +5.8% | $10.87 | $11.39 | $10.83 | 274,100 | |
| $10.74 | -0.43 | -3.8% | $11.23 | $11.23 | $10.70 | 273,600 | |
| $11.17 | -0.04 | -0.4% | $11.16 | $11.21 | $10.72 | 200,000 | |
| $11.21 | +0.13 | +1.2% | $11.10 | $11.34 | $10.98 | 342,200 | |
| $11.08 | -0.09 | -0.8% | $11.25 | $11.34 | $11.03 | 143,800 | |
| $11.17 | -0.14 | -1.2% | $11.16 | $11.20 | $11.00 | 128,800 | |
| $11.31 | +0.14 | +1.3% | $11.48 | $11.82 | $11.21 | 188,500 | |
| $11.17 | -0.15 | -1.3% | $11.16 | $11.31 | $10.98 | 73,000 | |
| $11.32 | +0.21 | +1.9% | $11.03 | $11.40 | $11.02 | 65,600 | |
| $11.11 | -0.12 | -1.1% | $11.27 | $11.32 | $10.92 | 148,700 | |
| $11.23 | +0.16 | +1.4% | $11.07 | $11.49 | $10.97 | 98,000 | |
| $11.07 | -0.01 | -0.1% | $11.02 | $11.13 | $10.83 | 96,200 | |
| $11.08 | +0.05 | +0.5% | $10.93 | $11.20 | $10.76 | 180,000 | |
| $11.03 | -0.20 | -1.8% | $11.15 | $11.16 | $10.58 | 328,300 | |
| $11.23 | +0.11 | +1.0% | $11.09 | $11.48 | $11.01 | 127,600 | |
| $11.12 | -0.56 | -4.8% | $11.66 | $11.66 | $11.08 | 113,600 | |
| $11.68 | +0.90 | +8.3% | $10.83 | $11.71 | $10.83 | 200,300 | |
| $10.78 | -0.25 | -2.3% | $11.12 | $11.12 | $10.72 | 217,100 | |
| $11.03 | +0.08 | +0.7% | $10.96 | $11.09 | $10.81 | 157,500 | |
| $10.95 | -0.15 | -1.4% | $11.09 | $11.10 | $10.55 | 203,100 | |
| $11.10 | +0.49 | +4.6% | $10.63 | $11.17 | $10.63 | 152,200 | |
| $10.61 | +0.13 | +1.2% | $10.38 | $10.67 | $10.12 | 256,100 | |
| $10.48 | +0.38 | +3.8% | $10.05 | $10.51 | $10.00 | 221,500 | |
| $10.10 | -0.56 | -5.3% | $10.59 | $10.59 | $10.02 | 315,300 | |
| $10.66 | -0.54 | -4.8% | $11.28 | $11.43 | $10.64 | 239,500 | |
| $11.20 | +0.56 | +5.3% | $10.69 | $11.23 | $10.56 | 159,700 | |
| $10.64 | -0.05 | -0.5% | $10.63 | $10.73 | $10.55 | 137,923 | |
| $10.69 | -0.46 | -4.1% | $11.15 | $11.18 | $10.54 | 170,833 | |
| $11.15 | +0.50 | +4.7% | $10.74 | $11.26 | $10.58 | 319,600 | |
| $10.65 | +0.655 | +6.6% | $9.97 | $10.71 | $9.97 | 386,600 | |
| $9.995 | -0.255 | -2.5% | $10.18 | $10.29 | $9.865 | 335,200 | |
| $10.25 | +0.14 | +1.4% | $9.77 | $10.43 | $9.69 | 276,900 | |
| $10.11 | +0.04 | +0.4% | $10.16 | $10.18 | $9.87 | 154,100 |
- Ticker
- NASDAQ:KROS
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Sep 29, 2026
Keros Therapeutics to Receive Additional Development Milestone Payment from Partner Takeda
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 24 slides
Latest news
Keros Therapeutics to Receive Additional Development Milestone Payment from Partner Takeda
Sep 29, 2026
Closed $11.19 (-0.8%) on Sep 29, 2026
Keros Therapeutics Announces the First Patient Dosing in the Phase 2 Clinical Trial Evaluating Rinvatercept in DMD
Sep 28, 2026
Closed $11.28 (-2.9%) on Sep 28, 2026
Keros Therapeutics Announces $5 Million Share Repurchase Authorization
Sep 8, 2026
Closed $11.31 (+1.3%) on Sep 9, 2026
Keros Therapeutics Reports Second Quarter 2026 Financial Results
Aug 3, 2026
Closed $10.25 (+1.4%) on Aug 4, 2026
Keros Therapeutics to Receive Development Milestone Payment from Partner Takeda
Jul 30, 2026
Closed $10.07 (-1.5%) on Jul 31, 2026
Keros Therapeutics Appoints Anne Prener to its Board of Directors
Jun 25, 2026
Closed $10.99 (+5.6%) on Jun 26, 2026
Keros Therapeutics Announces Participation at Goldman Sachs 47th Annual Global Healthcare Conference
Jun 1, 2026
Closed $10.55 (-3.2%) on Jun 2, 2026
Keros Therapeutics Reports Recent First Quarter 2026 Financial Results
May 14, 2026
Closed $10.99 (-8.3%) on May 14, 2026
Keros Therapeutics Announces Collaboration with Sean M. Healey & AMG Center for ALS
Mar 9, 2026
Closed $11.35 (+0.4%) on Mar 9, 2026
Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results
Mar 4, 2026
Closed $11.71 (-15.0%) on Mar 5, 2026
Decks
Investor Presentation (August 2026)
Investor deck · 24 slides · August 2026
Investor Presentation (March 2026)
Investor deck · 24 slides · Mar 4, 2026
Investor Presentation (January 2026)
Investor deck · 23 slides · Jan 9, 2026
Investor Presentation (August 2025)
Investor deck · 34 slides · Aug 6, 2025
Keros Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 14 in the last 12 months · 139 in all · newest Sep 29, 2026 · oldest 2020
- Decks
- 40 decks · latest August 2026
Where Keros Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:KROS · Home listing · This page | NASDAQ | United States | USD |
| BOATS:KROS | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Keros Therapeutics, Inc.